Antibodies face the challenge against human respiratory syncytial virus

Rory D. de Vries, Rik L. de Swart*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademic

2 Citations (Scopus)


In the December 22 issue of Cell, Bartsch et al. describe functional profiling of the antibody response to respiratory syncytial virus in human adults vaccinated with an experimental adenovirus-based prefusion-stabilized HRSV-F vaccine and subsequently intranasally challenged with HRSV. The authors identified various antibody effector functions as humoral correlates of protection.

Original languageEnglish
Pages (from-to)135-136
JournalCell Host and Microbe
Issue number1
Publication statusPublished - 11 Jan 2023


Dive into the research topics of 'Antibodies face the challenge against human respiratory syncytial virus'. Together they form a unique fingerprint.

Cite this